A simple point system with genetic and clinical variables would be useful in predicting risk for development of thiazolidinedione-associated edema

被引：0
|
作者：
Ragia, Georgia [1 ]
Manolopoulos, Vangelis G. [1 ]
机构：
[1] Democritus Univ Thrace, Sch Med, Lab Pharmacol & Clin Pharmacol, Alexandroupolis 68100, Greece
来源：
PHARMACOGENOMICS | 2012年 / 13卷 / 03期
关键词：
RANDOMIZED-TRIAL; ROSIGLITAZONE;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：263 / 264
页数：2
相关论文
共 3 条
  • [1] A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts
    Munoz, Andres
    Ay, Cihan
    Grilz, Ella
    Lopez, Sonia
    Font, Carme
    Pachon, Vanesa
    Castellon, Victoria
    Martinez-Marin, Virginia
    Salgado, Mercedes
    Martinez, Eva
    Calzas, Julia
    Ortega, Laura
    Ruperez, Ana
    Salas, Eduardo
    Pabinger, Ingrid
    Soria, Jose Manuel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16) : 2911 - +
  • [2] Development, validation, and comparative analysis of a simple clinical and laboratory-based risk score system for predicting and stratifying moderate-to-severe AKI after cardiac surgery
    Zeng, J. T.
    Su, X. T.
    Huang, X. H.
    Zheng, Z.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [3] What factors are associated with the development of myalgia in patients newly initiating statin therapy? An evaluation of clinical and genetic variables in the additional KIF6 risk offers better adherence to statins (AKROBATS) trial.
    Charland, Scott
    Superko, H. Robert
    Agatep, Barnabie
    Ryvkin, Miriam
    Herrera, Vivian
    Schrader, Bruce
    Shabbeer, Junaid
    Devlin, James
    Stanek, Eric
    [J]. PHARMACOTHERAPY, 2013, 33 (05): : E60 - E61
1